We have previously shown that the AML tumor suppressors, NR4A1 and NR4A3 function redundantly in Kasumi-1 AML-ETO positive human AML cells to inhibit AML cell growth and reprogram a subset of AML gene expression signatures [15]. Here, NR4A1 is linked to acute myeloid leukemia.